NIT
TMDX icon

NumerixS Investment Technologies’s Transmedics TMDX Stock Holding History

NumerixS Investment Technologies’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,500
Closed -$43K – 1228
2019
Q2 		$43K Buy
+1,500
New +$41K 0.01% 801

Other funds holding TMDX

ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NumerixS Investment Technologies's TMDX Position: Q3 2019 in Review

NumerixS Investment Technologies sold out of Transmedics (TMDX) in Q3 2019, closing a stake of 1,500 shares — an estimated $43K sold.

NumerixS Investment Technologies first reported a position in TMDX in Q2 2019 and held it in 1 quarter. The position peaked at $43K in Q2 2019. 50 funds tracked by Wall St. Rank hold TMDX as of Q3 2019.

  • NumerixS Investment Technologies reported no remaining Transmedics position as of Q3 2019 after selling out during the quarter.
  • NumerixS Investment Technologies sold 1,500 Transmedics shares in Q3 2019, an estimated $43K.
  • NumerixS Investment Technologies first reported a position in Transmedics in Q2 2019 and held it in 1 quarter.
  • NumerixS Investment Technologies's Transmedics position peaked at $43K in Q2 2019.
  • 50 funds tracked by Wall St. Rank held Transmedics as of Q3 2019.

Based on NumerixS Investment Technologies's 13F filing for Q3 2019, filed 13 Nov 2019.